Bowman & Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.78M Buy
18,486
+121
+0.7% +$11.8K 0.75% 35
2025
Q3
$1.75M Buy
18,365
+126
+0.7% +$11.6K 0.74% 37
2025
Q2
$1.59M Buy
18,239
+339
+2% +$28.7K 0.71% 41
2025
Q1
$1.61M Buy
17,900
+1,099
+7% +$98.3K 0.79% 37
2024
Q4
$1.34M Sell
16,801
-867
-5% -$75.1K 0.69% 40
2024
Q3
$1.59M Buy
17,668
+1,712
+11% +$144K 0.83% 31
2024
Q2
$1.26M Buy
15,956
+1,451
+10% +$119K 0.73% 40
2024
Q1
$1.26M Sell
14,505
-176
-1% -$15K 0.76% 35
2023
Q4
$1.21M Buy
14,681
+798
+6% +$60.8K 0.84% 34
2023
Q3
$1.09M Buy
13,883
+810
+6% +$67.8K 0.87% 30
2023
Q2
$1.15M Buy
13,073
+756
+6% +$65.1K 0.87% 27
2023
Q1
$993K Buy
12,317
+5,324
+76% +$434K 0.73% 31
2022
Q4
$543K Sell
6,993
-1,376
-16% -$112K 0.42% 50
2022
Q3
$676K Buy
8,369
+325
+4% +$29.2K 0.61% 33
2022
Q2
$722K Buy
8,044
+1,143
+17% +$116K 0.63% 36
2022
Q1
$766K Buy
6,901
+1,193
+21% +$126K 0.59% 33
2021
Q4
$594K Buy
+5,708
New +$661K 0.46% 43

Other funds holding MDT

Bowman & Company's MDT Position: Q4 2025 in Review

Bowman & Company increased its Medtronic (MDT) stake by 0.66% in Q4 2025, buying an estimated $11.8K and bringing the position to 18,486 shares worth $1.78M. The position accounts for 0.75% of the portfolio, ranked #35.

Bowman & Company first reported a position in MDT in Q4 2021 and has held it in 17 quarters since. 2,304 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Bowman & Company held 18,486 shares of Medtronic worth $1.78M as of Q4 2025.
  • Bowman & Company bought 121 Medtronic shares in Q4 2025, an estimated $11.8K.
  • Medtronic made up 0.75% of Bowman & Company's portfolio in Q4 2025, its #35 holding.
  • Bowman & Company first reported a position in Medtronic in Q4 2021 and has held it in 17 quarters since.
  • 2,304 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Bowman & Company's 13F filing for Q4 2025, filed 23 Jan 2026.